by Robin Dvorak | Jun 29, 2026
4D Molecular Therapeutics (4DMT, Nasdaq: FDMT) is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients.
by Robin Dvorak | Jun 4, 2026
Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel small molecule precision medicines for patients with kidney and metabolic diseases. Guided by its Compass™ platform, Maze pursues genetically...
by Robin Dvorak | May 7, 2026
Senseonics Holdings, Inc. (NASDAQ: SENS) is a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable...
